105 related articles for article (PubMed ID: 7493625)
1. Changes of mitochondrial mass in the hemopoietic stem cell line FDCP-mix after treatment with etoposide: a correlative study by multiparameter flow cytometry and confocal and electron microscopy.
Reipert S; Berry J; Hughes MF; Hickman JA; Allen TD
Exp Cell Res; 1995 Dec; 221(2):281-8. PubMed ID: 7493625
[TBL] [Abstract][Full Text] [Related]
2. DNA inclusions within autolytic cytoplasmic vacuoles of hemopoietic stem cell line FDCP-Mix.
Reipert S; Hickman JA; Allen TD
J Histochem Cytochem; 1996 Jun; 44(6):549-58. PubMed ID: 8666740
[TBL] [Abstract][Full Text] [Related]
3. Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide.
Facompré M; Wattez N; Kluza J; Lansiaux A; Bailly C
Mol Cell Biol Res Commun; 2000 Jul; 4(1):37-42. PubMed ID: 11152626
[TBL] [Abstract][Full Text] [Related]
4. A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNA.
Endresen PC; Prytz PS; Aarbakke J
Cytometry; 1995 Jun; 20(2):162-71. PubMed ID: 7545098
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques.
Ferlini C; Di Cesare S; Rainaldi G; Malorni W; Samoggia P; Biselli R; Fattorossi A
Cytometry; 1996 Jun; 24(2):106-15. PubMed ID: 8725659
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis.
Lizard G; Fournel S; Genestier L; Dhedin N; Chaput C; Flacher M; Mutin M; Panaye G; Revillard JP
Cytometry; 1995 Nov; 21(3):275-83. PubMed ID: 8582250
[TBL] [Abstract][Full Text] [Related]
7. Discrimination of respiratory dysfunction in yeast mutants by confocal microscopy, image, and flow cytometry.
Petit P; Glab N; Marie D; Kieffer H; Métézeau P
Cytometry; 1996 Jan; 23(1):28-38. PubMed ID: 14650438
[TBL] [Abstract][Full Text] [Related]
8. Topotecan-induced topoisomerase IIalpha expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment.
Chen S; Gomez SP; McCarley D; Mainwaring MG
Cancer Chemother Pharmacol; 2002 May; 49(5):347-55. PubMed ID: 11976828
[TBL] [Abstract][Full Text] [Related]
9. [Effect of etoposide and amsacrine on mitotic progression of GM-130 and Hep-2 cell lines. The flow cytometry assay].
Shatrova AN; Aksenov ND; Poletaev AI; Zenin VV
Tsitologiia; 2003; 45(1):59-68. PubMed ID: 12683237
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis of unstimulated human lymphocytes and DNA strand breaks induced by the topoisomerase II inhibitor etoposide (VP-16).
Tronov VA; Konoplyannikov MA; Nikolskaya TA; Konstantinov EM
Biochemistry (Mosc); 1999 Mar; 64(3):345-52. PubMed ID: 10205305
[TBL] [Abstract][Full Text] [Related]
11. Compared flow cytometric analysis of mitochondria using 10-n-nonyl acridine orange and rhodamine 123.
Benel L; Ronot X; Mounolou JC; Gaudemer F; Adolphe M
Basic Appl Histochem; 1989; 33(2):71-80. PubMed ID: 2757602
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of apoptosis induction by etoposide or hydroxyurea in mouse interleukin 3-dependent lymphoma cells.
Olmos G; Prieto A; Herráez A; Tejedor MC; Alvarez-Mon M; Diez JC
In Vivo; 2005; 19(2):455-64. PubMed ID: 15796210
[TBL] [Abstract][Full Text] [Related]
13. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
[TBL] [Abstract][Full Text] [Related]
14. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
Mekori YA; Oh CK; Metcalfe DD
J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
[TBL] [Abstract][Full Text] [Related]
15. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.
Potter AJ; Rabinovitch PS
Mutat Res; 2005 May; 572(1-2):27-44. PubMed ID: 15790488
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide.
Chen G; Shu J; Stacey DW
Oncogene; 1997 Oct; 15(14):1643-51. PubMed ID: 9349497
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism.
Shibata MA; Ito Y; Morimoto J; Otsuki Y
Carcinogenesis; 2004 Oct; 25(10):1887-98. PubMed ID: 15180944
[TBL] [Abstract][Full Text] [Related]
18. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
19. Variation of mitochondrial size during the cell cycle: A multiparameter flow cytometric and microscopic study.
Kennady PK; Ormerod MG; Singh S; Pande G
Cytometry A; 2004 Dec; 62(2):97-108. PubMed ID: 15536637
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering?
Serafino A; Sinibaldi-Vallebona P; Pierimarchi P; Bernard P; Gaudiano G; Massa C; Rasi G; Ranagnan G
Anticancer Res; 1999; 19(3A):1909-18. PubMed ID: 10470135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
